Sonoscape Medical Corp. (300633) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

300633 Sonoscape Medical Corp.

Watchlist

29.24
-1.02-3.37%

Market Closed Feb 28 15:00 CST

12.65BMarket Cap52.12P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

A Look At The Fair Value Of SonoScape Medical Corp. (SZSE:300633)
Simply Wall StFeb 24 17:20 ET
Guosen: Focus on AI + Medical, high-quality innovation, and value symbols with stable performance.
Guosen remains bullish on companies with differentiated innovation capabilities and overseas potential.
Zhitong FinanceFeb 19 20:58 ET
Nomura Adjusts SonoScape Medical's Price Target to 38.50 Yuan From 42.14 Yuan, Keeps at Buy
MT NewswiresFeb 19 04:20 ET · Ratings
Investors Still Waiting For A Pull Back In SonoScape Medical Corp. (SZSE:300633)
Simply Wall StFeb 7 18:41 ET
Sonoscape Medical Corp. (300633.SZ) issued a profit warning, expecting a net income of 0.136 billion to 0.182 billion yuan for the year 2024, a year-on-year decline of 59.95% to 70.07%.
Sonoscape Medical Corp. (300633.SZ) released its performance forecast for 2024, predicting...
Zhitong FinanceJan 17 07:36 ET
Open Healthcare: 2024 Annual Results Forecast
SZSIJan 17 06:26 ET · Announcements

Comments

Moomoo AI

Mar 25, 2024 01:05

SonoScape Medical Corp.'s high P/E ratio is worrisome considering its lower projected growth compared to the broader market. Investors retaining their stock at this high P/E ratio may face future disappointment if the P/E aligns with the growth outlook. Current prices are hard to justify unless conditions significantly improve.

Risks To Shareholder Returns Are Elevated At These Prices For SonoScape Medical Corp. (SZSE:300633)

Moomoo AI

Mar 11, 2024 21:07

Despite the recent downturn, long-term shareholders have seen a gain of 6% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering.

SonoScape Medical (SZSE:300633) Shareholders Have Earned a 19% CAGR Over the Last Three Years

Moomoo AI

Feb 26, 2024 01:10

SonoScape Medical's reinvestment for growth, despite lower short-term returns, has resulted in higher sales. The stock's modest 21% gain over five years suggests potential investment appeal if other fundamentals are sound.

Capital Allocation Trends At SonoScape Medical (SZSE:300633) Aren't Ideal

Moomoo AI

Jan 30, 2024 18:04

SonoScape Medical's consistent profit generation and significant insider ownership make it a strong contender for investor watchlists. The company's growth in profits and insider confidence are key highlights that add value for shareholders in the long term.

We Ran A Stock Scan For Earnings Growth And SonoScape Medical (SZSE:300633) Passed With Ease

Moomoo AI

Jan 16, 2024 21:31

SonoScape Medical's short term liquidity and more cash than debt suggest it can manage its debt safely. The company's 33% year-on-year EBIT growth is also a positive sign.